Knowledge Hub

Immunization reduces the risk of invasive pneumococcal disease, but those on immunosuppressants still have higher chances

Even though the incidence of invasive pneumococcal disease declined in all groups, including individuals on immunosuppressive drugs, following the introduction of pneumococcal conjugate vaccines for infants in Norway, people on chemotherapy were still 20 times more likely to get IPD than individuals not on any immunosuppressants, while individuals on long-term corticosteroids or other immunosuppressive drugs were around 6 times more likely to get the disease.

Full Citation:
Steens A, Winje BA, White RA et al.. 2019. Indirect effects of pneumococcal childhood vaccination in individuals treated with immunosuppressive drugs in ambulatory care: a case-cohort study. Clinical Infectious Diseases. 68(8).

Title of Article: Indirect effects of pneumococcal childhood vaccination in individuals treated with immunosuppressive drugs in ambulatory care: a case-cohort study

Author(s): Steens A, Winje BA, White RA et al.

Publication Year: 2019

Publication Name: Clinical Infectious Diseases

Publication Volume: 68(8)

Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/30957160

DOI (Digital Object Identifier): 10.1093/cid/ciy714

Topics: Health

Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia

Immunization Terms: Cancer

Countries: Norway

WHO Regions: Europe